Search Results - "Rosenau, Jens"

S3565 Non-Cirrhotic Portal Hypertension in a Patient with Polycystic Liver Disease and Segmental Colitis with Associated Diverticulosis by Fein, Aaron B., Thakur, Kshitij, Richardson, Brooks, Rosenau, Jens

Get full text

S2967 Drug-Induced Autoimmune Hepatitis Post Acute Liver Injury From Skullcap Supplements: An Unfortunate Case of Herbal Toxicity by Thakral, Nimish, Konjeti, Venkata Rajesh, Rosenau, Jens, Jalal, Ayesha T.

Get full text

Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors by ROSENAU, Jens, BAHR, Matthias J, VON WASIELEWSKI, Reinhard, MENGEL, Michael, SCHMIDT, Hartmut H. J, NASHAN, Björn, LANG, Hauke, KLEMPNAUER, Jürgen, MANNS, Michael P, BOEKER, Klaus H. W

“…Patients suffering from hepatic metastases of neuroendocrine tumors (NET) are potential candidates for orthotopic liver transplantation. Because recurrence…”
Get full text

A new side effect of immunosuppression: High incidence of hearing impairment after liver transplantation by Rifai, Kinan, Kirchner, Gabriele I., Bahr, Matthias J., Cantz, Tobias, Rosenau, Jens, Nashan, Björn, Klempnauer, Jürgen L., Manns, Michael P., Strassburg, Christian P.

“…Little is known about hearing impairment in patients after organ transplantation. We conducted a single‐center study to evaluate hearing impairment in patients…”
Get full text

Sa1546 THE MORTALITY RATE OF ACUTE ON CHRONIC LIVER FAILURE IN SETTING OF ACUTE HEPATITIS A INFECTION, A RETROSPECTIVE STUDY FROM A TERTIARY MEDICAL CENTER by Benrajab, Karim, Shokri, Elica, Ali, Saad Emhmed, Su, Leon, Chris-Olaiya, Abimbola, Thompson, Katherine, Ismail, Bahaaeldeen, Rosenau, Jens

Get full text

Su1626 RENAL REPLACEMENT THERAPY UTILIZATION AND MORTALITY IN ACUTE-ON-CHRONIC LIVER FAILURE WITH ACUTE KIDNEY INJURY by Chris-Olaiya, Abimbola, Olanipekun, Titi, Esperti, Shawn, Baliss, Michelle S., Benrajab, Karim, Rosenau, Jens, Cruz, Anna C. Dela

Get full text

Hepatitis C Virus Infection in Heart Transplantation: Is Ventricular Assist Device Therapy an Option? by Rajagopalan, Navin, Hoopes, Charles W., Rosenau, Jens

Get full text

Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation by Mederacke, Ingmar, Filmann, Natalie, Yurdaydin, Cihan, Bremer, Birgit, Puls, Florian, Zacher, Behrend Johann, Heidrich, Benjamin, Tillmann, Hans Ludger, Rosenau, Jens, Bock, C.-Thomas, Savas, Berna, Helfritz, Fabian, Lehner, Frank, Strassburg, Christian P, Klempnauer, Juergen, Wursthorn, Karsten, Lehmann, Ulrich, Manns, Michael P, Herrmann, Eva, Wedemeyer, Heiner

“…Background & Aims Chronic HDV infection is an inflammatory liver disease and liver transplantation (LTX) remains the only curative treatment option for most…”
Get full text

Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantation by Crittenden, Neil E., Buchanan, Laura A., Pinkston, Christina M., Cave, Barbra, Barve, Ashutosh, Marsano, Luis, McClain, Craig James, Jones, Christopher M., Marvin, Michael R., Davis, Eric G., Kuns‐Adkins, Candice B., Gedaly, Roberto, Brock, Guy, Shah, Malay B., Rosenau, Jens, Cave, Matthew C.

“…Although combination simeprevir (SIM) plus sofosbuvir (SOF) is an approved regimen for genotype 1 chronic hepatitis C virus (HCV), data regarding its safety…”
Get full text

1049 - Treatment Uptake in Hepatitis C virus Infected Patients in Central and Eastern Kentucky by Racho, Ronald G., Abdelwadoud, Moaz, Brown, John A., Santos, Patricia A., Kuns-Adkins, Candicd B., Cooper, Megan D., Wright, Maribeth P., Carr, Tonia, Dela Cruz, Anna C., Rosenau, Jens

Get full text

Treatment Uptake in Hepatitis C virus Infected Patients in Central and Eastern Kentucky by Racho, Ronald G, Abdelwadoud, Moaz, Brown, John A, Santos, Patricia A, Kuns-Adkins, Candicd B, Cooper, Megan D, Wright, Maribeth P, Carr, Tonia, Dela Cruz, Anna C, Rosenau, Jens

Get full text

Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation by Rosenau, Jens, Hooman, Nazanin, Hadem, Johannes, Rifai, Kinan, Bahr, Matthias J., Philipp, Gunnar, Tillmann, Hans L., Klempnauer, Juergen, Strassburg, Christian P., Manns, Michael P.

“…Hepatitis B vaccination after liver transplantation for hepatitis B–related liver disease has been investigated as an alternative strategy to reinfection…”
Get full text

Antibody to hepatitis B surface antigen trough levels and half‐lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation by Hooman, Nazanin, Rifai, Kinan, Hadem, Johannes, Vaske, Bernhard, Philipp, Gunnar, Priess, Andrea, Klempnauer, Juergen, Tillmann, Hans L., Manns, Michael P., Rosenau, Jens

“…Hepatitis B immunoglobulin (HBIG) administration remains an essential component of standard reinfection prophylaxis after liver transplantation for hepatitis B…”
Get full text

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection by Rosenau, J, Bahr, M J, Tillmann, H L, Trautwein, C, Klempnauer, J, Manns, M P, Böker KHW

“…Reinfection with hepatitis B virus (HBV) after liver transplantation (OLT) is associated with an unfavourable clinical course. Lamivudine/hepatitis B immune…”
Get full text

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study by Schlitt, Hans J, Barkmann, Annette, Böker, Klaus HW, Emmanouilidis, Nikos, Rosenau, Jens, Bahr, Matthias J, Tusch, Günter, Manns, Michael P, Nashan, Björn, Klempnauer, Jürgen

“…Renal dysfunction is a major complication of long-term immunosuppressive therapy with calcineurin inhibitors (CNI) in liver-transplant recipients. We undertook…”
Get full text

A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative HBeAg or HBV DNA levels by WIEGAND, Johannes, WEDEMEYER, Heiner, FINGER, Andrea, HEIDRICH, Benjamin, ROSENAU, Jens, MICHEL, Gerd, BOCK, C. Thomas, MANNS, Michael P, TILLMANN, Hans L

“…The elimination of hepatitis B virus surface antigen (HBsAg) is the final goal of hepatitis B treatment, but is rarely achieved. As quantitative assays for…”
Get full text

High rate of unperceived hearing loss in patients after liver transplantation by Rifai, Kinan, Pischke, Sven, Agne, Clemens, Rosenau, Jens, Klempnauer, Jürgen L., Manns, Michael P.

“…Rifai K, Pischke S, Agne C, Rosenau J, Klempnauer JL, Manns MP. High rate of unperceived hearing loss in patients after liver transplantation. :  Aim:  We…”
Get full text

Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus®) by Rifai, Kinan, Hafer, Carsten, Rosenau, Jens, Athmann, Christoph, Haller, Hermann, Peter Manns, Michael, Fliser, Danilo

“…Objective. Severe pruritus is a serious complication of cholestatic liver disease. Prometheus® is a recently introduced extracorporeal liver support system…”
Get full text

Changes in Plasma Amino Acids During Extracorporeal Liver Support by Fractionated Plasma Separation and Adsorption by Rifai, Kinan, Das, Anibh, Rosenau, Jens, Ernst, Thomas, Kretschmer, Ulrich, Haller, Hermann, Fliser, Danilo, Manns, Michael Peter

“…In patients with liver failure, amino acid dysbalance is common and associated with hepatic encephalopathy. Prometheus is a newly designed extracorporeal liver…”
Get full text

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration by Rosenau, Jens, Kreutz, Therese, Kujawa, Matthias, Bahr, Matthias J, Rifai, Kinan, Hooman, Nazanin, Finger, Andrea, Michel, Gerd, Nashan, Björn, Kuse, Ernst R, Klempnauer, Jürgen, Tillmann, Hans L, Manns, Michael P

“…Background/Aims Administration of hepatitis B immunoglobulin (HBIG) initially after liver transplantation of hepatitis B patients is considered important to…”
Get full text